Literature DB >> 32406283

A survey of psoriasis patients on biologics during COVID-19: a single centre experience.

Martina Burlando1, Luca Carmisciano2, Emanuele Cozzani1, Aurora Parodi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32406283     DOI： 10.1080/09546634.2020.1770165

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN： 0954-6634            Impact factor:   3.359


× No keyword cloud information.
  8 in total

1.  A survey of psoriasis patients on biologics during COVID-19: a high-epidemic area experience - Franche Comté, France.

Authors:  Irène Gallais-Serezal; Eve Puzenat; Joséphine Moreau; Flora Dresco; Fabien Pelletier; Charlée Nardin; François Aubin
Journal:  Eur J Dermatol       Date:  2021-02-01       Impact factor: 3.328

2.  Tumor necrosis factor inhibitors are associated with a decreased risk of COVID-19-associated hospitalization in patients with psoriasis-A population-based cohort study.

Authors:  Khalaf Kridin; Yochai Schonmann; Giovanni Damiani; Avi Peretz; Erez Onn; Dana Tzur Bitan; Arnon D Cohen
Journal:  Dermatol Ther       Date:  2021-06-05       Impact factor: 3.858

Review 3.  Psoriasis and COVID-19: A narrative review with treatment considerations.

Authors:  Ömer Faruk Elmas; Abdullah Demirbaş; Ömer Kutlu; Fatih Bağcıer; Mahmut Sami Metin; Kemal Özyurt; Necmettin Akdeniz; Mustafa Atasoy; Ümit Türsen; Torello Lotti
Journal:  Dermatol Ther       Date:  2020-07-09       Impact factor: 3.858

4.  Biologic drugs during COVID-19 outbreak.

Authors:  Maria A Montesu; Gabriele Biondi; Giovanni Sotgiu; Federica Sucato; Rosanna Satta
Journal:  Int J Dermatol       Date:  2020-08-06       Impact factor: 2.736

Review 5.  Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.

Authors:  Elia Rosi; Maria Thais Fastame; Antonella Di Cesare; Gianmarco Silvi; Nicola Pimpinelli; Francesca Prignano
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

6.  Association of COVID-19 with skin diseases and relevant biologics: a cross-sectional study using nationwide claim data in South Korea.

Authors:  S I Cho; Y E Kim; S J Jo
Journal:  Br J Dermatol       Date:  2020-10-13       Impact factor: 11.113

7.  Concerns related to the coronavirus disease 2019 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey.

Authors:  N D Loft; A-S Halling; L Iversen; C Vestergaard; M Deleuran; M K Rasmussen; C Zachariae; J P Thyssen; L Skov
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-09-17       Impact factor: 9.228

8.  National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.

Authors:  Joel M Gelfand; April W Armstrong; Stacie Bell; George L Anesi; Andrew Blauvelt; Cassandra Calabrese; Erica D Dommasch; Steve R Feldman; Dafna Gladman; Leon Kircik; Mark Lebwohl; Vincent Lo Re; George Martin; Joseph F Merola; Jose U Scher; Sergio Schwartzman; James R Treat; Abby S Van Voorhees; Christoph T Ellebrecht; Justine Fenner; Anthony Ocon; Maha N Syed; Erica J Weinstein; Jessica Smith; George Gondo; Sue Heydon; Samantha Koons; Christopher T Ritchlin
Journal:  J Am Acad Dermatol       Date:  2020-09-04       Impact factor: 15.487
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.